What Happened?
Shares of electronic signature company DocuSign (NASDAQ: DOCU) fell 6.1% in the morning session after the company reported first-quarter results that beat expectations but provided a muted forecast that failed to impress investors.
While DocuSign's first-quarter revenue of $830.2 million and adjusted earnings of $1.09 per share surpassed analyst estimates, its outlook tempered investor enthusiasm. For the upcoming second quarter, the company projected revenue with a midpoint of $867 million, which was almost identical to what analysts were already forecasting. The full-year guidance was also only slightly above expectations. This lack of a significant upward revision suggested to investors that growth might not accelerate as hoped.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy DocuSign? Access our full analysis report here, it’s free.
What Is The Market Telling Us
DocuSign’s shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 2 days ago when the stock dropped 4.5% on the news that software stocks declined for a second consecutive session, extending the profit-taking that began earlier in the week.
The broader market was essentially flat when the correction started the previous day: the S&P 500 was unchanged, the Nasdaq barely moved, confirming this was sector-level digestion, not broad risk-off selling.
To understand the pullback, you need to understand the depth of what preceded it. In a 48-hour span in early February 2026, roughly $285 billion was wiped from software stock valuations after Anthropic's Claude Cowork platform raised genuine fears that AI agents could make per-seat SaaS licensing obsolete, a moment the market called the "SaaSpocalypse."
Over the following months, the IGV fell more than a third from its September 2025 peak, hitting a 52-week low on April 10. At that point, approximately 75% of software stocks were screening as technically oversold.
The recovery was fast. The IGV rose 21% in May alone, its best monthly performance since October 2001, and gained approximately 40-44% from the April low. By June 2, it had crossed back into positive YTD territory for the first time, sitting approximately 11% below its all-time peak. Strong results from Snowflake and MongoDB gave the rebound fundamental cover. But the final push was options- and retail-driven, not institutional. On June 2, call volumes in the IGV outpaced puts, and Oracle options saw billions in premium trade with a three-to-one call-to-put ratio.
That is the key to understanding why portfolio managers are likely not defending these levels. Most institutional managers who cut software exposure during the SaaSpocalypse would have faced a recovery that moved faster than their mandates allowed for rebuilding positions. Rather than chase, watching for a pullback and a better entry might be better. For those already positioned from the early recovery, the rational move was to let names reset before adding.
DocuSign is down 26.3% since the beginning of the year, and at $47.77 per share, it is trading 48.6% below its 52-week high of $92.90 from June 2025. Investors who bought $1,000 worth of DocuSign’s shares 5 years ago would now be looking at only $198.24.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
